Alessandro Perrella: It is Not Only about “How High the CRP is”, but “in Which Patient” We are Measuring That Value
Alessandro Perrella, Director of the Unit of Emerging and Highly Contagious Infectious Diseases at Ospedali dei Colli, Infectious Disease Specialist at Antonio Cardarelli National Referral Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Antibiotics, adding:
“In a panorama where we often look for a single, linear answer, this study conducted in the Department of Infectious Diseases and Emerging Infectious Diseases shows that even a key parameter like PCR and CRP can lose its meaning if we do not take into account the ‘background noise’ generated by chronic inflammatory comorbidities.
In other words, it is not only about ‘how high the CRP is’, but ‘in which patient’ we are measuring that value.
From this perspective, we developed a ‘Comorbidity Confounder Score‘ (CCS), built on physiopathological grounds, which isolates the subgroups in which CRP regains a good ability to distinguish bacterial from viral infections, while still remaining an exploratory tool that has not yet been validated for clinical use.
The paper published yesterday in Antibiotics also presents a prototype of a ‘POC‑CRP Assistant‘, a web app that automates CCS calculation and provides a contextualized interpretation of CRP values, designed to integrate with new point‑of‑care (POC) systems and ward workflows.
This is only the beginning of a journey toward integrating AI‑based tools into clinical practice, but it is important to start precisely by recognizing ‘visible’ confounders and building simple, transparent solutions that are integrated into everyday practice.
The goal is not to replace clinicians, but to support them in making more informed decisions.
A huge thank you to the entire working group, without whom all this would have been impossible: Prof. Paola Salvatore, Francesca Futura Bernardi, Pierpaolo Di Micco, Ugo Trama, Rita Boenzi, Antimo di Spirito, Claudia Tiberio, Giusy di Flumeri, Nicolina Capoluongo and Mariano Bernardo.
Stay tuned:
We will be back with new amazing AI‑based strategies in Infectious Disease.”
Title: The Confounder in Plain Sight: A Retrospective Pilot Analysis on the Impact of Comorbidity on C-Reactive Protein Utility for Differentiating Bacterial vs. Viral Infections
Authors: Alessandro Perrella, Paola Salvatore, Pierpaolo Di Micco, Ugo Trama, Antimo Di Spirito, Claudia Tiberio, Mariano Bernardo, Nicolina Capoluongo, Giusy Di Flumeri, Rita Boenzi, Francesca Futura Bernardi

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 14, 2026, 19:35Daratumumab in Difficult-to-Treat iTTP: Updated Results from the International DarTTP Study
-
Jul 14, 2026, 17:1610 Posts Not To Miss from ISTH 2026, Part 3
-
Jul 14, 2026, 15:27Dianne E Van Der Wal: Celebrating Scientific Contributions at ISTH 2026
-
Jul 14, 2026, 15:13Alfonso Tafur: RIETE Registry Analysis Supports More Equitable Approaches to VTE Care
-
Jul 14, 2026, 15:03Heghine Khachatryan: Phase III Trial Results Support BAFF-R Inhibition in Corticosteroid-Refractory ITP
-
Jul 14, 2026, 14:51Nathan Connell: ISTH 2026 Highlights the Power of Lifelong Collaboration
-
Jul 14, 2026, 14:42Wolfgang Miesbach: VOYAGER1 Highlights Progress Toward Injection-Free Care in Hemophilia A
-
Jul 14, 2026, 12:08Elvira Grandone: Finding the Right LMWH Dose for Pregnant Patients Suffering From DVT
-
Jul 14, 2026, 12:05Eloïse Laouenan: From Washington to Paris – Join GETBO at ISTH 2026